Oxycodone Terminated Phase 3 Trials for Osteoarthritis (OA) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00985621Tanezumab In Osteoarthritis Of The Hip Or Knee